A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO)

Journals

1. Vromans R, Tenfelde K, Pauws S, van Eenbergen M, Mares-Engelberts I, Velikova G, van de Poll-Franse L, Krahmer E. Assessing the quality and communicative aspects of patient decision aids for early-stage breast cancer treatment: a systematic review. Breast Cancer Research and Treatment 2019;178(1):1 View
2. Herrmann A, Boyle F, Butow P, Hall A, Zdenkowski N. Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer. Health Science Reports 2018;1(1) View
3. de Ligt K, Spronk P, van Bommel A, Vrancken Peeters M, Siesling S, Smorenburg C. Patients' experiences with decisions on timing of chemotherapy for breast cancer. The Breast 2018;37:99 View
4. Zdenkowski N, Butow P, Spillane A, Douglas C, Snook K, Jones M, Oldmeadow C, Fewster S, Beckmore C, Boyle F. Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer. The Breast 2019;46:25 View
5. Witteman H, Maki K, Vaisson G, Finderup J, Lewis K, Dahl Steffensen K, Beaudoin C, Comeau S, Volk R. Systematic Development of Patient Decision Aids: An Update from the IPDAS Collaboration. Medical Decision Making 2021;41(7):736 View
6. Grant S, Kay S, Lacey J, Kumar S, Kerin-Ayres K, Stehn J, Gonzalez M, Templeton S, Heller G, Cockburn J, Wahlroos S, Malalasekera A, Mak C, Graham S. Feasibility study of a multimodal prehabilitation programme in women receiving neoadjuvant therapy for breast cancer in a major cancer hospital: a protocol. BMJ Open 2024;14(3):e080239 View